Letters

Rezulin

Letters | Press Accounts | Links

Press Accounts

March 23, 1999 | Washington Post
Is FDA Too Quick to Clear Drugs?

March 18, 1999 | Los Angeles Times
Death Toll Challenges Rezulin Safety Claim
Medicine: Fatalities climb despite drug maker´s assurances. FDA to reassess approval.

March 18, 1999 | Los Angeles Times
For Recent Victim, Risk Wasn´t Known
Medicine: Case No. 3174412-0 is Rosa Delia Valenzuela, who took Rezulin five weeks before she died. `I want this stuff off the market,´ son says.

January 28, 1999 | Los Angeles Times
Researcher´s Fees Point to Other Potential Conflicts at NIH
Government´s top expert on diabetes was paid by firm with stake in study he had role in.
More `questionable´ payments surface.

December 23, 1998 | Los Angeles Times
Lawmakers Question FDA on Rezulin OK
Drug: Letter by House Democrats asks why diabetes drug was kept on market despite deaths. They say issues go to `heart of public´s confidence.´

December 16, 1998 | Los Angeles Times
NIH Director Calls for Review of Scientist´s Ties to Firm
Rezulin: Questions arise after top diabetes researcher enters consulting agreement with company whose drug was chosen for use in study he helped oversee.

December 9, 1998 | Los Angeles Times
Waxman Queries NIH on Researcher's Ties
Rezulin: Congressman asks agency director how overseer of U.S. diabetes study received money from the company whose drug was being studied.

December 7, 1998 | Los Angeles Times
Drugmaker Hires NIH Researcher
Rezulin: Doctor, superior deny any conflict of interest. Questions are raised about claims Warner-Lambert made in promoting the pill.

December 6, 1998 | Los Angeles Times
`Fast Track´ Drug to Treat Diabetes Tied to 33 Deaths
Rezulin: The FDA dismissed warnings on the pill, but it was withdrawn in Britain. Agency and Warner-Lambert say treatment is safe when prescribed and used properly.